TABLE 1.
Demographic and Clinical Characteristics of the Sample (N=15)
| Noncompleters | ||||||
|---|---|---|---|---|---|---|
| Completers (N=8) | Adverse effects (N=4) | Other reasons (N=3) | ||||
| Characteristic | N | % | N | % | N | % |
| Age, mean (range) | 38.5 (19–60) | 43.75 (25–57) | 34.33 (26–48) | |||
| Gender | ||||||
| Male | 3 | 38 | 1 | 25 | 2 | 67 |
| Female | 5 | 63 | 3 | 75 | 1 | 33 |
| Ethnicity | ||||||
| Caucasian | 6 | 75 | 4 | 100 | 0 | — |
| African American | 0 | — | 0 | — | 1 | 33 |
| Asian-Pacific Islander | 1 | 13 | 0 | — | 1 | 33 |
| Hispanic | 1 | 13 | 0 | — | 1 | 33 |
| Full syndromal PTSDa | 5 | 63 | 2 | 50 | 2 | 67 |
a
Per the Clinician-Administered PTSD (Posttraumatic Stress Disorder) Scale (CAPS), remaining individuals with subthreshold PTSD were included in the study on account of having a CAPS distressing dreams score of ≥5 and a CAPS total score of ≥30.